EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS176-19281 
Organism
Homo sapiens 
Tissue/cell
SK-N-SH 
Coordinate
chr19:50096700-50097490 
Target genes
Number: 43             
NameEnsembl ID
AC011450.2ENSG00000235555
SLC6A16ENSG00000063127
CD37ENSG00000104894
AC011450.1ENSG00000197813
TEAD2ENSG00000074219
DKKL1ENSG00000104901
CCDC155ENSG00000161609
PTH2ENSG00000142538
SLC17A7ENSG00000104888
PIH1D1ENSG00000104872
ALDH16A1ENSG00000161618
FLT3LGENSG00000090554
RPL13AENSG00000142541
SNORD32AENSG00000201675
SNORD33ENSG00000199631
SNORD35AENSG00000200259
RPS11ENSG00000142534
SNORD35BENSG00000200530
FCGRTENSG00000104870
RCN3ENSG00000142552
NOSIPENSG00000142546
PRRG2ENSG00000126460
PRR12ENSG00000126464
RRASENSG00000126458
SCAF1ENSG00000126461
IRF3ENSG00000126456
PRMT1ENSG00000126457
C19orf76ENSG00000224420
CPT1CENSG00000169169
CTBENSG00000243829
TSKSENSG00000126467
AP2A1ENSG00000196961
FUZENSG00000010361
MED25ENSG00000104973
PTOV1ENSG00000104960
PNKPENSG00000039650
TBC1D17ENSG00000104946
AKT1S1ENSG00000204673
ATF5ENSG00000169136
NUP62ENSG00000213024
IL4I1ENSG00000104951
SIGLEC11ENSG00000161640
SIGLEC16ENSG00000161643
TF binding sites/motifs
Number: 8             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
NFYAMA0060.3chr19:50096828-50096839TCTGATTGGTT-6.62
NFYAMA0060.3chr19:50097159-50097170TCTGATTGGTT-6.62
NFYBMA0502.1chr19:50097229-50097244CTGATTGGCTCCTTC-6.38
NR2C2MA0504.1chr19:50097214-50097229TGACCCTTGACCCTC-6.42
Nr2f6MA0677.1chr19:50097214-50097228TGACCCTTGACCCT-6.77
RREB1MA0073.1chr19:50096977-50096997CCCCAACCCACCCCAATTCT+6.09
RxraMA0512.2chr19:50097214-50097228TGACCCTTGACCCT-6.87
ZNF263MA0528.1chr19:50097239-50097260CCTTCCCTTTTTCCCTCCCCA-6.01
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_68954chr19:50093383-50097450H9
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr195009680050097200
Enhancer Sequence
GGCCCCCATC CCGCCCCGCT TTGGGCTGGC CCTCCCCCTC CCCCCGAGGC AGCTGATTGG 60
CTGTTGAAAG TTCCGCCCCT CCTAATTGGC CGTGGCCCGT GCCGTGGCCC GCCCCTTGCT 120
GTGTCTCCTC TGATTGGTTG CCTTTGAGGC TGCTGGTCGC TGCTTCATTT CTCGCCGGAT 180
TCGTCCGCCC CTGCCTCGCC CCTCCCCTTT CGCTCCAATT GGCCCTGTTA CCATCAGCCC 240
CCAAATCCCA CCTTCTCTTC CAGGCTTTTC CGCCTCTCCC CAACCCACCC CAATTCTTTC 300
CCTCTGGGTT TGCCCTATTC TTTTGGCTCT TTGGAACTCT GAATTCTTTC TTCCTGATTC 360
CCTTTCTTCC TGATTGGCTC TAATTCTCTG GCCCGCCCTG TTTTATCTTA TTTTGCCCCA 420
TTGCCTTATT CTACCCACCT TGCCTTTGCC TCCAAGGTTT CTGATTGGTT CCCTCTTCCT 480
AGGGGTACTG GTAATGACAT GATGCTGTCC AGTTTGACCC TTGACCCTCC TGATTGGCTC 540
CTTCCCTTTT TCCCTCCCCA TCTTTTTTTC TGAACCCTCC CACTTAGCTC AATCCTTTCT 600
GACACGTTCT CTGGTCTTTC TTAGACTTCA TTGTCCCATC CTTTCCTCTT CCTTGCTGGA 660
AATATCCAAA TTTGGTCTCC CTCCCAGCCT TACTGAGGAC TCTGTTCTTT TGCTCCTGGC 720
TCTTTCGCTT CTAGATTTTT CTACACTTTT GTCTACCATT TCCTACCTGG GCCCCCTGTC 780
CTTATGACTG 790